REPORTING OF MEDICATION REGIMEN IN APPLIED STUDIES OF PERSONS WITH MENTAL RETARDATION AND ADHD
Saved in:
CHRISTIAN, L., ET AL., REPORTING OF MEDICATION REGIMEN IN APPLIED STUDIES OF PERSONS WITH MENTAL RETARDATION AND ADHD. Research in Developmental Disabilities, Vol. 18, no. 5 (1997), p. 319-327.
Ref.
62151
Location:
SIIS R.775
Palabras clave:
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Literatura científica, Trastornos de la conducta, Tratamiento, Utilización de servicios
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Literatura científica, Trastornos de la conducta, Tratamiento, Utilización de servicios
Similar Items: REPORTING OF MEDICATION REGIMEN IN APPLIED STUDIES OF PERSONS WITH MENTAL RETARDATION AND ADHD
- EFFECTS AND NONEFFECTS OF METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD
- IMPLICATIONS OF BEHAVIORAL PHARMACOLOGY RESEARCH FOR APPLIED BEHAVIOR ANALYSES: JEAB'S SPECIAL ISSUE CELEBRATING THE CONTRIBUTIONS OF JOSEPH V. BRADY (MARCH 1994)
- EFFECT OF STIMULANT MEDICATION ON CHILDREN WITH ATTENTION DEFICIT DISORDER: A "REVIEW OF REVIEWS"
- PREDICTION OF RESPONSE TO METHYLPHENIDATE AMONG CHILDREN WITH ADHD AND MENTAL RETARDATION
- PREDICTION OF RESPONSE TO METHYLPHENIDATE AMONG CHILDREN WITH ADHD AND MENTAL RETARDATION
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS